Literature DB >> 3100411

Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma.

M Leader, M Collins, J Patel, K Henry.   

Abstract

In this study we examined the staining reactivity of commercially available antisera to factor VIII related antigen (F VIII RAg) and Ulex europaeus agglutinin I (UEA-I) on sections from 230 formalin fixed paraffin embedded tumours. These included 196 sarcomas, 20 carcinomas and 14 angiomas. All angiomas showed positive staining for F VIII RAg; all carcinomas showed negative staining; the vasoformative areas of all angiosarcomas stained positively but only four of six angiosarcomas showed positive staining of their solid areas; of seven Kaposi's sarcomas, all showed positive staining of vessels and six showed positive staining of the spindle cell component. In the remaining 181 non-vascular sarcomas there was a false positive result in four tumours (2.2%), three of which had a history of irradiation. Pre-radiotherapy biopsies of these three tumours stained negatively with anti-F VIII RAg. UEA-I was demonstrated in all the angiomas studied, in all angiosarcomas (including the solid components) and in well-formed vessels of all Kaposi's sarcomas, but only in the spindle cell component of 3/6. However, there was an unacceptably high rate of false positive staining amongst the carcinomas and non-vascular sarcomas. In conclusion, F VIII RAg is a specific but not a sensitive marker of angiosarcomas; UEA-I is a sensitive but not a specific marker of angiosarcomas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100411     DOI: 10.1111/j.1365-2559.1986.tb02555.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.

Authors:  N Wernert; M B Raes; P Lassalle; M P Dehouck; B Gosselin; B Vandenbunder; D Stehelin
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

2.  Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.

Authors:  E Poblet; F Gonzalez-Palacios; F J Jimenez
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  Desmin: its value as a marker of muscle derived tumours using a commercial antibody.

Authors:  M Leader; M Collins; J Patel; K Henry
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Immunostaining for CD31 and CD34 in Kaposi sarcoma.

Authors:  R Russell Jones; G Orchard; B Zelger; E Wilson Jones
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

5.  Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum.

Authors:  S Muller; I M Chesner; M J Egan; D C Rowlands; M J Collard; E T Swarbrick; J Newman
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

Review 6.  KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.

Authors:  M Cassidy; B Loftus; A Whelan; B Sabt; D Hickey; K Henry; M Leader
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 7.  Hepatic haemangiosarcoma in a patient with psoriasis and Crohn's disease.

Authors:  C J McCarthy; M Norton; C O'Morain
Journal:  Ir J Med Sci       Date:  1992-12       Impact factor: 1.568

8.  Haemangioblastoma. An immunohistochemical study of ten cases.

Authors:  J W Grant; P J Gallagher; C Hedinger
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Myoglobin: an evaluation of its role as a marker of rhabdomyosarcomas.

Authors:  M Leader; J Patel; M Collins; K Henry
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.